Chromosome 21 Reveals Sparse Gene Content

The unveiling of the DNA sequences of human chromosomes represents a new chapter in the unfolding story of genomics, but one with roots in the half-century-old field of cytogenetics. Chromosome-level looks can reveal the specific genes behind certain traits and disorders while providing information on genome organization. The diminutive chromosome 21--the smallest of the human contingent, despite its number as next to last--is the fourth to be described. Its debut in mid-May attracted attentio

Written byRicki Lewis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

The unveiling of the DNA sequences of human chromosomes represents a new chapter in the unfolding story of genomics, but one with roots in the half-century-old field of cytogenetics. Chromosome-level looks can reveal the specific genes behind certain traits and disorders while providing information on genome organization.

The diminutive chromosome 21--the smallest of the human contingent, despite its number as next to last--is the fourth to be described. Its debut in mid-May attracted attention because 21 is a chromosome with a familiarity factor, in the form of Down syndrome, usually caused by an extra copy of the chromosome. A consortium of 62 scientists, working in Japan, Germany, France, Switzerland, the United States, and the United Kingdom, contributed to the massive effort.1 Chromosome 21's surprisingly sparse gene content has been compared to a desert or even a black hole, calling for a reexamination of total genome size estimates.

The sequencing of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies